Enfermedades Sistémicas de Base Autoinmune

Hernandez-Florez, D; Valor, L; de la Torre, I; Nieto, JC; Martinez-Estupinan, L; Gonzalez, C; Lopez-Longo, FJ; Monteagudo, I; Garrido, J; Naredo, E; Carreno, L.

Comparison of two ELISA versions for infliximab serum levels in patients diagnosed with ankylosing spondylitis

RHEUMATOLOGY INTERNATIONAL. 2015; 35(6): 1021-1025 Nº de citas: 7 [doi:10.1007/s00296-014-3180-2]

Pego-Reigosa, JM; Rua-Figueroa, I; Lopez-Longo, FJ; Galindo-Izquierdo, M; Calvo-Alen, J; Olive-Marques, A; del Campo, V; Garcia-Yebenes, MJ; Loza-Santamaria, E; Blanco, R; Melero-Gonzalez, R; Vela-Casasempere, P; Oton-Sanchez, T; Tomero-Muriel, E; Uriarte-Isacelaya, E; Fito-Manteca, MC; Freire-Gonzalez, M; Narvaez, J; Fernandez-Nebro, A; Zea-Mendoza, A; Carlos Rosas, J.

Analysis of disease activity and response to treatment in a large Spanish cohort of patients with systemic lupus erythematosus

LUPUS. 2015; 24(7): 720-729 Nº de citas: 24 [doi:10.1177/0961203314563818]

Janta, I; Martinez-Estupinan, L; Valor, L; Montoro, M; Rodriguez, OB; Aragues, IH; Bello, N; Hernandez-Floez, D; Hinojosa, M; Martinez-Barrio, J; Nieto-Gonzalez, JC; Ovalles-Bonilla, JG; Gonzalez, CM; Lopez-Longo, FJ; Monteagudo, I; Naredo, E; Carreno, L.

Comparison between full and tapered dosages of biologic therapies in psoriatic arthritis patients: clinical and ultrasound assessment

CLINICAL RHEUMATOLOGY. 2015; 34(5): 935-942 Nº de citas: 20 [doi:10.1007/s10067-015-2880-7]

Torrente-Segarra, V; Salman-Monte, TC; Rua-Figueroa, I; Calvo-Alen, J; Lopez-Longo, FJ; Galindo, M; Pego-Reigosa, JM.

Clinical and serological differences between juvenile-onset and adult-onset systemic lupus erythematosus patients from a national registry of patients (RELESSER)

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2015; 33(3): 7-8

Rua-Figueroa, I; Lopez-Longo, FJ; Galindo, M; Calvo-Alen, J; Del Campo, V; Fernandez-Nebro, A; Olive-Marques, A; Hernandez-Cruz, B; Erausquin, C; Pego-Reigosa, JM.

Cumulative incidence, associated factors and clinical impact of severe infections in a cohort of over 3,500 patients with Systemic Lupus Erythematosus

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2015; 33(3): 43-43

Pego-Reigosa, J; Iglesias, AL; Lopez-Longo, F; Galindo, M; Calvo, J; Una, J; Balboa, V; Olive, A; Mourino, C; Oton, T; Ibanez, J; Horcada, L; Sanchez, A; Blanco, R; Montilla, C; Melero, R; Diez, E; Fernandez, M; Ruiz, E; Hernandez, J; Gantes, M; Hernandez, B; Pecondon, A; Lozano, N; Bonilla, G; Torrente, V; Rua-Figueroa, I.

Damage and mortality in Systemic Lupus Erythematosus: Cluster analysis of patients from SLE Registry from the Spanish Society for Rheumatology (RELESSER)

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2015; 33(3): 39-39

Manrique-Arija, S; Ordonez-Canizares, MC; Fernandez-Nebro, A; Pego-Reigosa, JM; Lopez-Longo, FJ; Galindo, M; Calvo-Alen, J; Rua-Figueroa, I.

Analysis of cardiovascular events (CVE) in a large nation-wide cohort of patients with systemic lupus erythematosu: RELESSER Registry

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2015; 33(3): 38-38

Iglesias, AL; Rua-Figueroa, I; del Campo, V; Lopez-Longo, F; Galindo, M; Calvo, J; Hernandez, I; Belmonte, M; Erausquin, C; Tomero, E; Blanco, R; Calvo-Rio, V; Uriarte, E; Casasempere, PV; Freire, M; de Toro, J; Raya, E; Fernandez-Nebro, A; Horcada, L; Pego-Reigosa, J.

Thrombotic thrombocytopenic purpura in patients from the Systemic Lupus Erythematosus registry of the Spanish Society of Rheumatology (RELESSER)

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2015; 33(3): 75-76

Montes, A; Perez-Pampin, E; Navarro-Sarabia, F; Moreira, V; de la Sema, AR; Magallares, B; Vasilopoulos, Y; Sarafidou, T; Fernandez-Nebro, A; Ordonez, MD; Narvaez, J; Canete, JD; Marquez, A; Pascual-Salcedo, D; Joven, B; Carreira, P; Moreno-Ramos, MJ; Caliz, R; Ferrer, MA; Garcia-Portales, R; Blanco, FJ; Magro, C; Raya, E; Valor, L; Alegre-Sancho, JJ; Balsa, A; Martin, J; Plant, D; Isaacs, J; Morgan, AW; Barton, A; Wilson, AG; Gomez-Reino, JJ; Gonzalez, A.

Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: a case-only study

ARTHRITIS RESEARCH & THERAPY. 2015; 17: Nº de citas: 11 [doi:10.1186/s13075-015-0571-z]

Alvarez, MM; Chong, OY; Janta, I; Gonzalez, C; Lopez-Longo, J; Monteagudo, I; Valor, L; Garrido, J; Lau, IS; Rosman, A; Naredo, E; Carreno, L.

Relation of Doppler ultrasound synovitis versus clinical synovitis with changes in native complement component levels in rheumatoid arthritis patients treated with biologic disease-modifying anti-rheumatic drugs

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2015; 33(2): 141-145 Nº de citas: 4

Becerra, E; Scully, MA; Leandro, MJ; Heelas, EO; Westwood, JP; De La Torre, I; Cambridge, G.

Effect of rituximab on B cell phenotype and serum B cell-activating factor levels in patients with thrombotic thrombocytopenic purpura

CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2015; 179(3): 414-425 Nº de citas: 18 [doi:10.1111/cei.12472]

Torp-Pedersen, S; Christensen, R; Szkudlarek, M; Ellegaard, K; D'Agostino, MA; Iagnocco, A; Naredo, E; Balint, P; Wakefield, RJ; Torp-Pedersen, A; Terslev, L.

Power and Color Doppler Ultrasound Settings for Inflammatory Flow

ARTHRITIS & RHEUMATOLOGY. 2015; 67(2): 386-395 Nº de citas: 91 [doi:10.1002/art.38940]

Cambridge, G; De La Torre, I.

Response to Rituximab: Has the Original Hypothesis Been Confirmed?

CURRENT PHARMACEUTICAL DESIGN. 2015; 21(2): 212-220 Nº de citas: 3

Rua-Figueroa, I; Richi, P; Lopez-Longo, FJ; Galindo, M; Calvo-Alen, J; Olive-Marques, A; Loza-Santamaria, E; Vicente, SP; Erausquin, C; Tomero, E; Horcada, L; Uriarte, E; Sanchez-Atrio, A; Rosas, J; Montilla, C; Fernandez-Nebro, A; Rodriguez-Gomez, M; Vela, P; Blanco, R; Freire, M; Silva, L; Diez-Alvarez, E; Ibanez-Barcelo, M; Zea, A; Narvaez, J; Martinez-Taboada, V; Marenco, JL; de Castro, MF; Fernandez-Berrizbeitia, O; Hernandez-Beriain, JA; Gantes, M; Hernandez-Cruz, B; Perez-Venegas, JJ; Pecondon, A; Marras, C; Carreira, P; Bonilla, G; Torrente, V; Castellvi, I; Alegre, J; Moreno, M; Raya, E; de la Pena, PG; Vazquez, T; Aguirre, A; Quevedo, V; Pego-Reigosa, JM.

Comprehensive Description of Clinical Characteristics of a Large Systemic Lupus Erythematosus Cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) With Emphasis on Complete Versus Incomplete Lupus Differences

MEDICINE. 2015; 94(1): Nº de citas: 40 [doi:10.1097/MD.0000000000000267]

Roth, J; Jousse-Joulin, S; Magni-Manzoni, S; Rodriguez, A; Tzaribachev, N; Iagnocco, A; Naredo, E; D'Agostino, MA; Collado, P.

Definitions for the Sonographic Features of Joints in Healthy Children

ARTHRITIS CARE & RESEARCH. 2015; 67(1): 136-142 Nº de citas: 107 [doi:10.1002/acr.22410]

Garcia-Bermudez, M; Lopez-Mejias, R; Genre, F; Castaneda, S; Corrales, A; Llorca, J; Gonzalez-Juanatey, C; Ubilla, B; Miranda-Filloy, JA; Pina, T; Gomez-Vaquero, C; Rodriguez-Rodriguez, L; Fernandez-Gutierrez, B; Balsa, A; Pascual-Salcedo, D; Lopez-Longo, FJ; Carreira, P; Blanco, R; Martin, J; Gonzalez-Gay, MA.

Lack of Association between JAK3 Gene Polymorphisms and Cardiovascular Disease in Spanish Patients with Rheumatoid Arthritis

Biomed Research International. 2015; 2015: Nº de citas: 7 [doi:10.1155/2015/318364]

Rodriguez-Rodriguez, L; Lamas, JR; Abasolo, L; Baena, S; Olano-Martin, E; Collado, A; Rivera, J; Fernandez-Gutierrez, B.

The rs3771863 single nucleotide polymorphism of the TACR1 gene is associated to a lower risk of sicca syndrome in fibromyalgia patients

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2015; 33(1): 33-40 Nº de citas: 7

Rivera, J; Vallejo, MA; Offenbacher, M.

Classifying fibromyalgia patients according to severity: the combined index of severity in fibromyalgia

RHEUMATOLOGY INTERNATIONAL. 2014; 34(12): 1683-1689 Nº de citas: 6 [doi:10.1007/s00296-014-3029-8]